Handling uncertainty When asked: How long have I got? it is tempting to give a finite (Oh, three months) or range (Anything from a month to six months) of time. But such predictions are usually inaccurate, tend to err on the optimistic side, and cause problems for patients and their families. Patients then pace themselves according to the time they believe is left. If they deteriorate earlier than expected and are prevented from achieving planned goals they will feel cheated and bitter. Relatives can find an unexpectedly prolonged survival ("borrowed time") hard to cope with because they have used up their physical and emotional resources. So it is better to acknowledge your uncertainty and the difficulties that this will cause. Doctor: You asked me how long he has. The trouble is, I don't know. I If this strategy fails look for and challenge any inconsistencies between the patient's experiences and perceptions.
Doctor: You say you were far bigger in this pregnancy than in your two previous ones. Did you consider why that might be?
Mrs J: I thought it was just one of those things. I didn't think anything more about it. Doctor: Are you sure? Mrs J: Yes I am sure it was a normal pregnancy. The reason I'm still feeling so weak is because I didn't take it too well.
The patient had developed ovarian cancer which was so advanced that little treatment could be offered. She preferred to deny this and insisted that her symptoms represented normal sequelae of pregnancy.
If challenging inconsistencies fails to dent denial check if there is "a window." Do this by asking: "I can understand that you feel it is an infection. But 
Conclusion
The best way to validate our guidelines is to try them out in practice. Either they will work and promote confidence or they will prompt you to develop other strategies.
We thank the Cancer Research Campaign and Help the Hospices for their support. (Accepted 19J7uly 1988) ANY QUESTIONS Is there any association between stopping long term beta blockade treatment for hypertension and subsequent myocardial infarction?
Firstly, we must consider the risk of stopping treatment of hypertension and, secondly, the risk per se of stopping beta blockade. The first is easier to address: though hypertension is a risk factor for myocardial infarction, we have no clear evidence that either initiating or stopping treatment influences the likelihood of an attack.
The possibility that withdrawing beta blockers may provoke infarction has often been considered,' and could conceivably arise in one of two ways. The first is by withdrawal of a protective effect that may until then have been keeping a heart attack at bay. Beta blockers can be effective in the secondary prevention of heart attacks so an increase in attack rate could perhaps occur after stopping treatment for hypertension at least in subjects who have already had infarcts. The major secondary prevention trials with beta blockade did not address this possible consequence of treatment withdrawal, but any risk is likely to be small. A second mechanism for increase in risk as a result of stopping treatment could follow from induced changes in the beta receptors in the heart. Treatment 
